ondansetron has been researched along with erythromycin in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (30.00) | 18.2507 |
2000's | 5 (25.00) | 29.6817 |
2010's | 9 (45.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Haga, N; Inatomi, N; Itoh, Z; Mizumoto, A; Shiba, Y; Yamamoto, O | 1 |
Fiorucci, S; Morelli, A; Santucci, L | 1 |
Coremans, G; Janssens, J; Peeters, T; Tack, J; Vantrappen, G; Wilmer, A | 1 |
Inui, A; Itoh, Z; Mizumoto, A; Omura, S; Satoh, M; Shiba, Y | 1 |
Arruebo, MP; Guerrero-Lindner, E; Murillo, MD; Plaza, MA | 1 |
Costa, A; Crema, F; d'Angelo, L; De Ponti, F; Gibelli, G | 1 |
Athanasakis, H; Chrysos, E; Epanomeritakis, E; Koutsoumbi, P; Tsiaoussis, J; Vassilakis, JS; Xynos, E; Zoras, O | 1 |
Athanasakis, E; Chrysos, E; Karkavitsas, N; Tsiaoussis, J; Xynos, E; Zoras, OJ | 1 |
Ali, MZ; Ebied, RS; Kamel, HH; Kamel, NM; Omar, SH; Osman, ES; Radwan, KG | 1 |
Dechering, DG; Eckardt, L; Ellermann, C; Fehr, M; Fischer, C; Frommeyer, G; Kochhäuser, S; Lange, PS; Wasmer, K | 1 |
1 review(s) available for ondansetron and erythromycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for ondansetron and erythromycin
Article | Year |
---|---|
The effect of erythromycin on human esophageal motility is mediated by serotonin receptors.
Topics: Adult; Atropine; Double-Blind Method; Erythromycin; Esophagus; Female; Gastrointestinal Agents; Humans; Male; Manometry; Ondansetron; Peristalsis; Receptors, Serotonin | 2000 |
Octreotide enhances the accelerating effect of erythromycin on gastric emptying in healthy subjects.
Topics: Adult; Double-Blind Method; Drug Synergism; Erythromycin; Female; Gastric Emptying; Gastrointestinal Agents; Humans; Male; Octreotide; Ondansetron; Radiopharmaceuticals; Serotonin Antagonists; Technetium Tc 99m Sulfur Colloid | 2002 |
Sub-antibiotic doses of erythromycin as a prokinetic in abdominal surgeries: reviving the old.
Topics: Administration, Oral; Adult; Digestive System Surgical Procedures; Dose-Response Relationship, Drug; Double-Blind Method; Erythromycin; Female; Gastrointestinal Agents; Humans; Male; Metoclopramide; Middle Aged; Ondansetron; Young Adult | 2010 |
16 other study(ies) available for ondansetron and erythromycin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Stimulatory mechanism of EM523-induced contractions in postprandial stomach of conscious dogs.
Topics: Animals; Anti-Bacterial Agents; Atropine; Dipeptides; Dogs; Dopamine; Eating; Erythromycin; Hexamethonium; Indoles; Motilin; Muscle Contraction; Naloxone; Ondansetron; Serotonin Antagonists; Stomach; Substance P | 1995 |
5-hydroxytryptamine 3-receptor antagonist modulates gallbladder emptying and motilin release induced by erythromycin.
Topics: Adult; Erythromycin; Female; Food; Gallbladder Emptying; Humans; Male; Motilin; Ondansetron; Serotonin Antagonists | 1993 |
5-hydroxytryptamine-3 receptors are involved in the initiation of gastric phase-3 motor activity in humans.
Topics: Adult; Digestive System; Digestive System Physiological Phenomena; Duodenum; Erythromycin; Female; Humans; Jejunum; Male; Motilin; Motor Activity; Motor Neurons; Ondansetron; Pyloric Antrum; Receptors, Serotonin; Stomach | 1993 |
Effect of nonpeptide motilin agonist EM523 on release of gut and pancreatic hormones in conscious dogs.
Topics: Animals; Atropine; Dogs; Erythromycin; Gastrointestinal Hormones; Motilin; Ondansetron; Pancreatic Hormones; Serotonin Antagonists; Vagotomy | 1996 |
Effect of motilin on gastrointestinal myoelectric activity in conscious rabbits.
Topics: Animals; Atropine; Consciousness; Drug Interactions; Erythromycin; Gastrointestinal Agents; Hexamethonium; Motilin; Myoelectric Complex, Migrating; Ondansetron; Rabbits | 1996 |
In vivo characterization of the colonic prokinetic effect of erythromycin in the rabbit.
Topics: Animals; Anti-Bacterial Agents; Atropine; Calcium Channel Blockers; Colon; Dose-Response Relationship, Drug; Electrodes, Implanted; Erythromycin; Female; Gastrointestinal Motility; In Vitro Techniques; Male; Muscarinic Antagonists; Nifedipine; Ondansetron; Rabbits; Serotonin Antagonists; Stimulation, Chemical | 1997 |
Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Domperidone; Drug Interactions; Erythromycin; Female; Heart Conduction System; Heart Rate; Isolated Heart Preparation; Ondansetron; Proof of Concept Study; Rabbits; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |